FEATURES

Ocuphire Pharma Announces Acquisition of Opus Genetics

FARMINGTON HILLS, Mich.—Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company, has announced the all-stock acquisition of Opus Genetics, Inc., a clinical-stage gene therapy company for inherited retinal diseases (IRDs).  Read more...


Bausch + Lomb Receives Health Canada Approval for Soothe Antibiotic Drops

VAUGHAN, Ontario—Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company, has announced Health Canada has approved Soothe Antibiotic Drops, an over-the-counter drop to treat external infections of the eye and ear, such as bacterial conjunctivitis and swimmer’s ear.  Read more...


SUNY College of Optometry Foundation Announces Distinguished Honorees for Inaugural Value of Vision Breakfast

NEW YORK—SUNY College of Optometry Foundation has announced that it will be hosting the first annual Value of Vision Breakfast on Tuesday, November 19, 2024, from 8:30 to 10 a.m.  Read more...


MOST READ STORIES

CURRENT
ISSUE

September 2024

September 2024

FEATURED COURSE

20/20 Pro to Pro Continuing Education